Hypermethylated CLDN11 can be utilized as a biomarker for the early detection of CRC melanoma, and gastric cancer (Agarwal et al., 2009; Karagiannis et al., 2014; Guo et al., 2019). The gene discussed is CLDN11; the disease is gastric cancer.